The MSF Scientific Days International conference is a platform for researchers, innovators, and advocates in humanitarian global health to come together to discuss and challenge research from within the sector.
Session
From trials to tools: solutions for humanitarian health
| Antibiogo as an innovative solution to detect antimicrobial resistance: From an operational need to a CE-marked diagnostic test available for low-income and middle-income countries Nada Malou, Antibiogo Program Manager, MSF |
| Malaria Anticipation Project: Development of a predictive malaria early warning system for anticipatory action in Jonglei State, South Sudan Tom Wardley, MSF Kim West, MSF |
| Application of the Médecins Sans Frontières clinical trial transparency policy: cost analysis of TB-PRACTECAL, a multicentre phase 2–3 trial in drug-resistant tuberculosis Dzintars Gotham, Consultant, MSF |
| Once-weekly fosravuconazole versus daily itraconazole, with surgery, in eumycetoma patients in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial Ahmed Fahal, Director, Mycetoma Research Center Co-authors: Ahmed ES, Bakhiet SM, Bakheet OE, Fahal LA, Mohamed AA, Mohhamedelamin ESW, Bahar ME, Attalla HY, Siddig EE, Mahmoud NA, Musa AM, van de Sande WWJ, Scherrer B, Oyieko P, Egondi T, Onyango K, Hata K, Chu WY, Dorlo TPC, Nyaoke BA, Strub-Wourgaft N, Zijlstra EE |
Presentation
| Towards an arsenic-free oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: a new tool for disease elimination Elisabeth Baudin, France Co-authors: Mordt OV, Alves D, Seixas J, Lemerani M, Wamboga C, Lejon V, Signorell A, Matovu E |
